Assembly Biosciences, Inc. (NASDAQ:ASMB), a biotechnology firm based in South San Francisco, California, announced its participation in two upcoming investor conferences. Senior management will engage in fireside chats at the Jefferies 2026 Global Healthcare Conference on June 3, 2026, at 4:20 p.m. ET, and at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026, at 8:40 a.m. ET. Assembly Biosciences focuses on developing innovative small-molecule therapeutics aimed at serious viral and liver diseases, including herpesvirus, hepatitis delta virus (HDV), cholestatic liver diseases, and hepatitis B virus (HBV). The company is committed to improving patient outcomes through advanced treatment options. Interested parties can register for the webcasts via the Events and Presentations section of Assembly Bio's website, where replays will also be accessible post-event.